Brain Cancer Trial, Recruiting NCT06015802 Sponsor: Sun Yat-sen University Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06015802
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a pituitary neuroendocrine tumour (a type of growth on the pituitary gland) based on medical imaging, whether or not the tumour produces hormones (confirmed by hormone testing)

Who may not be able to join:

  • People whose previous tissue sample results showed pituitary cancer (rather than a non-cancerous tumour)
  • People who have previously received radiation therapy, chemotherapy, immunotherapy, or targeted therapy
  • People who have a known genetic condition that can cause the body to produce too many hormones, such as Carney syndrome, McCune-Albright syndrome, or Multiple Endocrine Neoplasia Type 1 (confirm with trial site regarding the full list)
  • People who have a neuroendocrine tumour located somewhere other than the pituitary gland
  • People who have had a major surgery within one month before joining, or surgery on the pituitary gland through the nasal/sinus area within three months before joining
  • People who are experiencing a serious hormonal emergency involving the pituitary gland, thyroid gland, or adrenal glands
  • People who have a serious disease affecting other hormone-producing glands, other solid organ tumours, or a serious blood condition
  • People who have serious damage to the heart, kidneys, or liver
  • People who have a severe mental health or neurological condition
  • People with very poorly controlled blood sugar levels, very poorly controlled high blood pressure, or who are in a medical emergency

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2021
Est. completion
1 March 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease progression or recurrence after surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov